Table 2.
Class* | Gene count |
Total length in bp (% coverage) |
Mean gene length (bp) |
Mean exon length |
Number of exons |
---|---|---|---|---|---|
Known genes | 613 | 41,424,864 (37.9) | 68,440 | 322 | 6,628 |
Novel genes | 147 | 4,707,061 (4.3) | 32,024 | 474 | 605 |
Novel transcripts | 176 | 4,655,574 (4.3) | 26,974 | 296 | 683 |
Putative genes | 213 | 1,912,134 (1.7) | 8,980 | 244 | 488 |
Total genes | 1,149 | 51,435,292 (47.0) | 46,407 | 326 | 8,404 |
Processed pseudogenes | 397 | 459,658 (0.4) | 1,157 | 709 | 475 |
Unprocessed pseudogenes | 29 | 405,851 (0.4) | 13,994 | 165 | 216 |
Total structures | 1,575 | 52,022,232 (48.0) | 34,405 | 342 | 9,095 |
Classes follow those laid down in ref. 4 and are based on the longest transcript of each gene; the total number of exons from all alternative transcripts is 14,640. Known genes, identical to known human cDNA or protein and have an entry in Locuslink; novel genes, have an ORF and are identical to spliced human ESTs or have some similarity to other cDNA/proteins (all species); novel transcripts, similar to novel genes but have ambiguous ORFs or multiple evidence for non-coding RNA; putative genes, with identity to 1–3 spliced ESTs but do not contain evidence for an ORF; pseudogenes, similar to known proteins but contain a frameshift and/or stop codon that disrupts the ORF.